[Ambulatory treatment experience with lidoflazine in ischemic heart disease]. 1980

V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov

UI MeSH Term Description Entries
D008013 Lidoflazine Coronary vasodilator with some antiarrhythmic action. Clinium,Ordiflazine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
February 1973, Vrachebnoe delo,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
January 1979, Acta cardiologica. Supplementum,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
October 1984, Klinicheskaia meditsina,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
January 1980, Terapevticheskii arkhiv,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
March 1976, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
January 1981, Kardiologiia,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
September 1979, Sovetskaia meditsina,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
June 1978, Vrachebnoe delo,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
June 1997, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
V P Pmerantsev, and N A Ivanova, and V S Zadionchenko, and A L Vertkin, and A I Martynov
June 1971, Zdravookhranenie Rossiiskoi Federatsii,
Copied contents to your clipboard!